ATE241638T1 - 15-gliedrige ketolid-lactame mit antibakterieller wirkung - Google Patents

15-gliedrige ketolid-lactame mit antibakterieller wirkung

Info

Publication number
ATE241638T1
ATE241638T1 AT99911955T AT99911955T ATE241638T1 AT E241638 T1 ATE241638 T1 AT E241638T1 AT 99911955 T AT99911955 T AT 99911955T AT 99911955 T AT99911955 T AT 99911955T AT E241638 T1 ATE241638 T1 AT E241638T1
Authority
AT
Austria
Prior art keywords
lactames
ketolide
antibacterial effect
antibacterial
effect
Prior art date
Application number
AT99911955T
Other languages
English (en)
Inventor
Gorjana Lazarevski
Gabrijela Kobrehel
Zeljko Kelneric
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Application granted granted Critical
Publication of ATE241638T1 publication Critical patent/ATE241638T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT99911955T 1998-04-06 1999-04-02 15-gliedrige ketolid-lactame mit antibakterieller wirkung ATE241638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR980189A HRP980189B1 (en) 1998-04-06 1998-04-06 Novel 15-membered lactams ketolides
PCT/HR1999/000004 WO1999051616A1 (en) 1998-04-06 1999-04-02 15-membered lactams ketolides with antibacterial activity

Publications (1)

Publication Number Publication Date
ATE241638T1 true ATE241638T1 (de) 2003-06-15

Family

ID=10946724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99911955T ATE241638T1 (de) 1998-04-06 1999-04-02 15-gliedrige ketolid-lactame mit antibakterieller wirkung

Country Status (26)

Country Link
US (1) US6110965A (de)
EP (1) EP1070077B1 (de)
JP (1) JP2002510701A (de)
KR (1) KR100600463B1 (de)
CN (1) CN1141312C (de)
AR (1) AR019261A1 (de)
AT (1) ATE241638T1 (de)
AU (1) AU3046499A (de)
BG (1) BG64600B1 (de)
BR (1) BR9910115A (de)
CA (1) CA2327775C (de)
DE (1) DE69908338T2 (de)
DK (1) DK1070077T3 (de)
EE (1) EE04283B1 (de)
ES (1) ES2200512T3 (de)
HR (1) HRP980189B1 (de)
HU (1) HUP0101817A3 (de)
IL (2) IL138837A0 (de)
NO (1) NO317982B1 (de)
PL (1) PL193742B1 (de)
PT (1) PT1070077E (de)
RU (1) RU2211222C2 (de)
SI (1) SI1070077T1 (de)
SK (1) SK284169B6 (de)
UA (1) UA70941C2 (de)
WO (1) WO1999051616A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
AU2001263812B2 (en) * 2000-03-28 2004-09-23 Sandoz Ag Granulated particles with masked taste
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
CA2458135A1 (en) * 2001-08-21 2003-03-06 Pfizer Products Inc. Single dose azithromycin for treating respiratory infections
US7271154B2 (en) 2002-02-15 2007-09-18 Merckle Gmbh Antibiotic conjugates
EP1483579A4 (de) 2002-02-15 2006-07-12 Merckle Gmbh Konjugate biologisch aktiver verbindungen, verfahren zu ihrer herstellung und verwendung, formulierung und pharmazeutische anwendungen davon
AU2003219770B2 (en) 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
RS20050008A (sr) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., Nova jedinjenja,kompozicije i metode za lečenje inflamatornih oboljenja i stanja
HRP20020779A2 (en) 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
WO2005030227A1 (en) * 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
PT1851236E (pt) 2005-01-13 2010-10-25 Glaxosmithkline Zagreb Macrólidos com actividade anti-inflamatória
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
RU2455308C2 (ru) * 2006-05-01 2012-07-10 Тайсо Фармасьютикал Ко., Лтд. Макролидные производные
WO2009007988A1 (en) * 2007-07-11 2009-01-15 Alembic Limited Process for the preparation of 6-o-methylerythromycin a 9-oxime
CN102378763A (zh) 2009-01-30 2012-03-14 葛兰素集团有限公司 消炎的大环内酯
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
PT2673285T (pt) * 2010-12-09 2017-10-19 Wockhardt Ltd Resumo
DK3883647T3 (da) * 2018-11-19 2026-03-23 Zikani Therapeutics Inc C10-alkylensubstituerede 13-ledede makrolider og anvendelser deraf
CA3156529A1 (en) * 2019-10-29 2021-05-06 Sudhir Nambiar Substantially pure clarithromycin 9-oxime and its preparation thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5166967A (en) * 1990-08-27 1992-11-24 Fabian Carl E Markers for dental x-ray film and packets for simplified film mounting
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5202434A (en) * 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
EP0549040A1 (de) * 1991-12-20 1993-06-30 Merck & Co. Inc. Verfahren zur Herstellung von 4"-Derivaten von 9-Deoxo-8a-Aza-8a-Alkyl-8a-Homoerythromycin A
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US5686587A (en) * 1993-05-19 1997-11-11 Pfizer Inc. Intermediate for azithromycin
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция

Also Published As

Publication number Publication date
PL193742B1 (pl) 2007-03-30
AR019261A1 (es) 2002-02-13
WO1999051616A1 (en) 1999-10-14
DE69908338T2 (de) 2004-04-08
NO20005015D0 (no) 2000-10-05
UA70941C2 (uk) 2004-11-15
BR9910115A (pt) 2000-12-26
JP2002510701A (ja) 2002-04-09
EP1070077A1 (de) 2001-01-24
CN1141312C (zh) 2004-03-10
DE69908338D1 (de) 2003-07-03
EE04283B1 (et) 2004-04-15
HRP980189A2 (en) 2000-12-31
IL138837A0 (en) 2001-10-31
US6110965A (en) 2000-08-29
SK284169B6 (sk) 2004-10-05
PT1070077E (pt) 2003-10-31
NO20005015L (no) 2000-12-04
KR20010034754A (ko) 2001-04-25
BG64600B1 (bg) 2005-08-31
EP1070077B1 (de) 2003-05-28
SI1070077T1 (en) 2004-02-29
AU3046499A (en) 1999-10-25
CA2327775A1 (en) 1999-10-14
SK15022000A3 (sk) 2001-03-12
PL343441A1 (en) 2001-08-13
EE200000587A (et) 2002-04-15
HUP0101817A3 (en) 2003-07-28
CA2327775C (en) 2007-08-07
HK1036457A1 (en) 2002-01-04
KR100600463B1 (ko) 2006-07-13
BG104913A (en) 2001-08-31
ES2200512T3 (es) 2004-03-01
RU2211222C2 (ru) 2003-08-27
DK1070077T3 (da) 2003-09-22
HUP0101817A2 (hu) 2001-11-28
CN1301268A (zh) 2001-06-27
HRP980189B1 (en) 2004-04-30
IL138837A (en) 2006-10-05
NO317982B1 (no) 2005-01-17

Similar Documents

Publication Publication Date Title
ATE241638T1 (de) 15-gliedrige ketolid-lactame mit antibakterieller wirkung
DE60012526D1 (de) Hydrophile polypropylenfasern mit antimikrobieller wirkung
EP1005356A4 (de) Neuartige antibiotika
DK1147121T3 (da) Ketolidantibiotika
DE69935135D1 (de) Topische hormonhaltige zusammensetzung mit systemischer wirkung
ATE269075T1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
IS5528A (is) Ný makrólíð
DK2301541T3 (da) Antibiotiske sammensætninger til behandling af øjet
DE69934805D1 (de) Substituierte imidazole mit cytokin-inhibierender wirkung
DE69838651D1 (de) Erythromycinderivate
DE69919769D1 (de) 3,6-Ketal-Makrolidantibiotika
DE69821964D1 (de) 3'-n-modifizierte 6-0 substituierte erythromycin ketolide derivate mit antibakterieller wirkung
DE60125678D1 (de) Vermittlungstelle mit Flusssteurungverwaltung
EE200100245A (et) Uued makroliidsed antibiootikumid
DE69927008D1 (de) Verbindungen mit kalzilytischer wirkung
ID27201A (id) Komposisi farmasi
ATE408596T1 (de) Pleuromutilinderivate mit antibakterieller wirkung
HUP0303935A3 (en) Ketolide antibacterial compounds
PT1077681E (pt) Composicao farmaceutica contendo levotiroxina sodio
PT1124567E (pt) Composicoes tamponadas para dialise
FR2806857B1 (fr) Systeme de modulation de largeur d'impulsion de type lineaire
DK1185237T3 (da) Synergistisk antibakteriel kombination
ATE315042T1 (de) 9a-azalide mit antibakterieller wirkung
FI981298A7 (fi) Polymeerikoostumukset
ID26295A (id) Komposisi keras-ultraviolet

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1070077

Country of ref document: EP

REN Ceased due to non-payment of the annual fee